These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 8171050)

  • 1. Lessons from transgenic mouse lines expressing sickle hemoglobin.
    Nagel RL
    Proc Soc Exp Biol Med; 1994 Apr; 205(4):274-81. PubMed ID: 8171050
    [No Abstract]   [Full Text] [Related]  

  • 2. A second generation transgenic mouse model expressing both hemoglobin S (HbS) and HbS-Antilles results in increased phenotypic severity.
    Fabry ME; Sengupta A; Suzuka SM; Costantini F; Rubin EM; Hofrichter J; Christoph G; Manci E; Culberson D; Factor SM; Nagel RL
    Blood; 1995 Sep; 86(6):2419-28. PubMed ID: 7662990
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Transgenic knockout mice exclusively expressing human hemoglobin S after transfer of a 240-kb betas-globin yeast artificial chromosome: A mouse model of sickle cell anemia.
    Chang JC; Lu R; Lin C; Xu SM; Kan YW; Porcu S; Carlson E; Kitamura M; Yang S; Flebbe-Rehwaldt L; Gaensler KM
    Proc Natl Acad Sci U S A; 1998 Dec; 95(25):14886-90. PubMed ID: 9843985
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Transgenic mouse models of sickle cell disease.
    Beuzard Y
    Curr Opin Hematol; 1996 Mar; 3(2):150-5. PubMed ID: 9372066
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Transgenic knockout mice with exclusively human sickle hemoglobin and sickle cell disease.
    Pászty C; Brion CM; Manci E; Witkowska HE; Stevens ME; Mohandas N; Rubin EM
    Science; 1997 Oct; 278(5339):876-8. PubMed ID: 9346488
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Knockout-transgenic mouse model of sickle cell disease.
    Ryan TM; Ciavatta DJ; Townes TM
    Science; 1997 Oct; 278(5339):873-6. PubMed ID: 9346487
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Human sickle hemoglobin in transgenic mice.
    Ryan TM; Townes TM; Reilly MP; Asakura T; Palmiter RD; Brinster RL; Behringer RR
    Science; 1990 Feb; 247(4942):566-8. PubMed ID: 2154033
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mouse models of sickle cell disease.
    Beuzard Y
    Transfus Clin Biol; 2008; 15(1-2):7-11. PubMed ID: 18502677
    [TBL] [Abstract][Full Text] [Related]  

  • 9. In vivo demonstration of red cell-endothelial interaction, sickling and altered microvascular response to oxygen in the sickle transgenic mouse.
    Kaul DK; Fabry ME; Costantini F; Rubin EM; Nagel RL
    J Clin Invest; 1995 Dec; 96(6):2845-53. PubMed ID: 8675655
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Fibrinogen deficiency, but not plasminogen deficiency, increases mortality synergistically in combination with sickle hemoglobin SAD in transgenic mice.
    Roszell NJ; Danton MJ; Jiang M; Witte D; Daugherty C; Grimes T; Girdler B; Anderson KP; Franco RS; Degen JL; Joiner CH
    Am J Hematol; 2007 Dec; 82(12):1044-8. PubMed ID: 17722076
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Arginine supplementation improves rotorod performance in sickle transgenic mice.
    Fasipe FR; Ubawike AE; Eva R; Fabry ME
    Hematology; 2004 Aug; 9(4):301-5. PubMed ID: 15621739
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Transgenic sickle mice are markedly sensitive to renal ischemia-reperfusion injury.
    Nath KA; Grande JP; Croatt AJ; Frank E; Caplice NM; Hebbel RP; Katusic ZS
    Am J Pathol; 2005 Apr; 166(4):963-72. PubMed ID: 15793278
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mechanisms of vascular instability in a transgenic mouse model of sickle cell disease.
    Nath KA; Shah V; Haggard JJ; Croatt AJ; Smith LA; Hebbel RP; Katusic ZS
    Am J Physiol Regul Integr Comp Physiol; 2000 Dec; 279(6):R1949-55. PubMed ID: 11080057
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pathophysiology of a sickle cell trait mouse model: human alpha(beta)(S) transgenes with one mouse beta-globin allele.
    Noguchi CT; Gladwin M; Diwan B; Merciris P; Smith R; Yu X; Buzard G; Fitzhugh A; Keefer LK; Schechter AN; Mohandas N
    Blood Cells Mol Dis; 2001; 27(6):971-7. PubMed ID: 11831863
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Towards a mouse model for sickle cell disease: HB SAD.
    Trudel M; Garel MC; Saadane N; Rouyer-Fessard P; Vidaud D; Costantini F; Beuzard Y
    Nouv Rev Fr Hematol (1978); 1990; 32(6):407-8. PubMed ID: 2101873
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Review: the sickle hemoglobinopathies--genetic analyses of common phenocopies and new molecular approaches to treatment.
    Steinberg MH
    Am J Med Sci; 1984 Nov; 288(4):169-74. PubMed ID: 6208780
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Correction of the sickle cell mutation in embryonic stem cells.
    Chang JC; Ye L; Kan YW
    Proc Natl Acad Sci U S A; 2006 Jan; 103(4):1036-40. PubMed ID: 16407095
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The transgenic SAD mouse: a model of human sickle cell glomerulopathy.
    De Paepe ME; Trudel M
    Kidney Int; 1994 Nov; 46(5):1337-45. PubMed ID: 7853792
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Improved diagnosis of sickle cell mutation by a robust amplification refractory polymerase chain reaction.
    Simsek M; Daar S; Ojeli H; Bayoumi R
    Clin Biochem; 1999 Nov; 32(8):677-80. PubMed ID: 10638955
    [No Abstract]   [Full Text] [Related]  

  • 20. RBC adhesion to cremaster endothelum in mice with abnormal hemoglobin is increased by topical endotoxin.
    Liu XW; Pierangeli SS; Barker J; Wick TM; Hsu LL
    Ann N Y Acad Sci; 1998 Jun; 850():391-3. PubMed ID: 9668564
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.